Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease
News
Treatment has been completed in a Phase 2 clinical trial of brilacidin for ulcerative proctitis and ulcerative proctosigmoiditis — a study that led to six of the 12 patients’ bowel ... Read more